Generating destination analysis
Compass Direction
Earnings IntelligenceAI-Powered
Compass Score
Key Numbers
Market Cap
$200B
P/E
32
Revenue Growth
+4.0%
Gross Margin
N/A
ROE
N/A
About Thermo Fisher Scientific
Thermo Fisher Scientific is a mega-cap healthcare company listed on the NYSE, blending biotech and genomics initiatives alongside its core business operations. Life sciences tools giant providing instruments, reagents, and services to biotech. Valued at 32x trailing earnings with a $200B market capitalization, Thermo Fisher Scientific has delivered modest revenue growth with revenue moving +4% over the past year.
Expert Coverage
Unlock Full TMO Analysis
Expert analysis and coverage for Thermo Fisher Scientific
Upgrade to CompassFull access to 500+ ratings • $9/month
Price & Technical Analysis
Price vs 200DMA
DMA Convergence
50 DMA
200 DMA
More in Biotech & Genomics
Eli Lilly and Company
Pharma giant leading the GLP-1 revolution with Mounjaro and Zepbound weight-loss drugs.
Alnylam Pharmaceuticals
RNA interference therapeutics leader with approved treatments for rare diseases.
CRISPR Therapeutics
Pioneer of CRISPR gene-editing therapy with first approved treatment for sickle cell disease.
Beam Therapeutics
Base editing platform with differentiated gene-editing pipeline.